4117 fundamentals
An in-depth look to GENERAL BIOLOGICAL CORP operating, investing, and financing activities
4117 free cash flow for H1 24 is -1.28 B TWD. For 2023, 4117 free cash flow was -198.07 M TWD and operating cash flow was 225.94 M TWD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM